Drug
Datopotamab Deruxtecan Dlnk
Datopotamab Deruxtecan Dlnk: highest development phase Approved, developed by Daiichi Sankyo. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Daiichi Sankyo
Trials
| Drug | Phase | Indication |
|---|---|---|
| DATROWAY | Approved |
Latest
No recent events.
Follow Datopotamab Deruxtecan Dlnk on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.